ArticleRSC advances2021
Highly sensitive and selective detection of naproxen
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 31 citations in OpenAlex.
- Rapid Eukaryotic Impedimetric Biosensing of Naproxen and Isoniazid: A Proof-of-Concept for Acute Toxicity Monitoring.Biosensors · 2026Article
- Buttressing ligand-binding pockets in de novo designed NTF2-like domains.Protein science : a publication of the Protein Society · 2025Article
- Advances in electrochemical sensors for naproxen detection: Mechanisms, performance factors, and emerging challenges.Heliyon · 2025Review
- An Advanced Molecularly Imprinted Photochemical Sensor Based Carbon Quantum dots for Highly Sensitive Detection of Chloramphenicol in Food.Journal of fluorescence · 2024Article
- Fluorescence sensing by carbon nanoparticles.Nanoscale advances · 2022Review
- Cucurbituril-assisted sensitive fluorescence detection and quantitation of naproxen drug in wastewater samples: Guest-host characterization and HPLC investigation.Frontiers in chemistry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The overuse and inappropriate discharge of naproxen, a common anti-inflammatory medication and an emerging contaminant in water, is detrimental to human health and bodies of water. Here, we design a fluorescent sensor based on molecularly imprinted carbon dots (CDs) for highly selective detection of trace amounts of naproxen. The CDs were encapsulated into the pores of silica through a sol-gel based method and provide fluorescent signal. After removal of the template molecules, a molecularly imprinted polymer layer was formed and the fluorescence of the CDs sensor was selectively quenched by naproxen. A detection limit of as low as 0.03 μM and a linear range of 0.05-4 μM for detecting naproxen in aqueous solution were obtained. High recoveries of naproxen levels in waste water and urine samples for practical application were also achieved. In addition, the accurate detection performance of sensor was maintained during the UV degradation of naproxen.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.